This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Corium's (CORI) Shares Surge on Merger Agreement With Gurnet
by Zacks Equity Research
Corium International (CORI) announces merger agreement with Gurnet Point Capital. The deal values Corium at $12.50 per share in cash and will take the company private.
Corium International (CORI) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Corium (CORI) delivered earnings and revenue surprises of 12.82% and 14.22%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Moving Average Crossover Alert: Corium International, Inc. (CORI)
by Zacks Equity Research
Moving Average Crossover Alert: Corium International, Inc. (CORI)
Why the Earnings Streak Will Continue for Corium International (CORI)
by Zacks Equity Research
Corium International (CORI) is in a good position to beat earnings at its next report as it has a favorable Zacks Rank and positive Earnings ESP.
CymaBay Therapeutics (CBAY) in Focus: Stock Moves 11.4% Higher
by Zacks Equity Research
CymaBay Therapeutics (CBAY) was a big mover last session, as the company saw its shares rise more than 11% on the day.
Corium International (CORI) Catches Eye: Stock Jumps 11.9%
by Zacks Equity Research
Corium International, Inc. (CORI) moved big last session, as the company saw its shares rise almost 12% on the day.
Amphastar (AMPH) in Focus: Stock Moves 9.7% Higher
by Zacks Equity Research
Amphastar Pharmaceuticals (AMPH) was a big mover last session, as the company saw its shares rise almost 10% on the day.
AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session
by Zacks Equity Research
AxoGen, Inc. (AXGN) shares rose a little above 6% in the last trading session.
Can The Uptrend Continue for Corium International (CORI)?
by Zacks Equity Research
Investors certainly have to be happy with Corium International Inc (CORI) and its short term performance
Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View
by Zacks Equity Research
Shire plc (SHPG) reported first-quarter 2017 earnings of $3.63 per American Depositary Share (ADS), beating the Zacks Consensus Estimate of $3.22 and up 13.8% from the year-ago quarter figure of $3.19.
Anthem (ANTM) to Report Q1 Earnings: A Beat in the Cards?
by Zacks Equity Research
We expect Anthem Inc. (ANTM) to beat expectations when it reports first-quarter 2017 results on Apr 26, before the market opens.